[HTML][HTML] Novel approaches to tuberculosis vaccine development
SHE Kaufmann, J Weiner, CF von Reyn - International Journal of Infectious …, 2017 - Elsevier
SHE Kaufmann, J Weiner, CF von Reyn
International Journal of Infectious Diseases, 2017•ElsevierTuberculosis (TB) remains the deadliest infectious disease. The widely used bacille
Calmette–Guérin (BCG) vaccine offers only limited protection against TB. New vaccine
candidates for TB include subunit vaccines and inactivated whole-cell vaccines, as well as
live mycobacterial vaccines. Current developments in TB vaccines are summarized in this
review.
Calmette–Guérin (BCG) vaccine offers only limited protection against TB. New vaccine
candidates for TB include subunit vaccines and inactivated whole-cell vaccines, as well as
live mycobacterial vaccines. Current developments in TB vaccines are summarized in this
review.
Summary
Tuberculosis (TB) remains the deadliest infectious disease. The widely used bacille Calmette–Guérin (BCG) vaccine offers only limited protection against TB. New vaccine candidates for TB include subunit vaccines and inactivated whole-cell vaccines, as well as live mycobacterial vaccines. Current developments in TB vaccines are summarized in this review.
Elsevier